Replies to post #22476 on NorthWest Biotherapeutics Inc (NWBO)

[Pyrrhonian]

The two big ones are partnership and completed randomized Ph II.

[maverick_1]

My own personal experience with small cap biotechs is CONTRARY to what you've stated:

There are a lot of small cap bio-techs with greater than 50% institutional ownership. It isn't like Insty's don't invest in these stocks. What are the "broad strokes" they are using that excludes NWBO, but includes a lot of other small and highly speculative companies?

With sad reference to AF... When defined as under $350 mln market capitalization I find FEW that have 50% instl ownership UNLESS they were the likes of KERX; SRPT(which AustinMedia inappropriately compared with NWBO!);DSCI;ACAD etc.

Why instl are excluding NWBO goes back to my Aug '14 post on:
Why Institutions own less than 13% that was in response to 2OOK+ NWBO owned by poster BasinStBlues: DNDN blighted the entire Immunotherapy landscape since 2006!! with their failed strategic BLUNDERS of major manufacturing cost OVERRUNS caused by how their technology is applied: cumbersome; not fully powered; requiring specialized application etc.